Bionano Genomics, Inc. Revenues
Bionano Genomics, Inc. (BNGO) reported Revenues of $4.01 million for the 3-month period ending 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2019-03-14
- Bionano Genomics, Inc. revenues for the quarter ending 2018-12-31 was $4.01M, a 41.07% increase year-over-year.
- Bionano Genomics, Inc. revenues for the quarter ending 2018-09-30 was $2.83M, a 3.12% increase year-over-year.
- Bionano Genomics, Inc. revenues for the quarter ending 2018-06-30 was $3.39M, a 54.36% increase year-over-year.
- Bionano Genomics, Inc. revenues for the quarter ending 2018-03-31 was $1.77M, a 2.77% increase year-over-year.
- Bionano Genomics, Inc. revenues for fiscal 2018 was $12.00M, a 26.26% increase from fiscal 2017.
- Bionano Genomics, Inc. revenues for fiscal 2017 was $9.51M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2018-12-31 | $4.01M 10-K · filed 2019-03-14 | $6.84M derived: sum of 2 quarters · filed 2019-03-14 | $10.23M derived: sum of 3 quarters · filed 2019-03-14 | $12.00M 10-K · filed 2019-03-14 |
| 2018-09-30 | $2.83M 10-K · filed 2019-03-14 | $6.22M derived: sum of 2 quarters · filed 2019-03-14 | $7.99M derived: sum of 3 quarters · filed 2019-03-14 | $10.83M derived: sum of 4 quarters · filed 2019-03-14 |
| 2018-06-30 | $3.39M 10-K · filed 2019-03-14 | $5.16M derived: sum of 2 quarters · filed 2019-03-14 | $8.00M derived: sum of 3 quarters · filed 2019-03-14 | $10.75M derived: sum of 4 quarters · filed 2019-03-14 |
| 2018-03-31 | $1.77M 10-K · filed 2019-03-14 | $4.61M derived: sum of 2 quarters · filed 2019-03-14 | $7.36M derived: sum of 3 quarters · filed 2019-03-14 | $9.55M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-12-31 | $2.85M 10-K · filed 2019-03-14 | $5.59M derived: sum of 2 quarters · filed 2019-03-14 | $7.78M derived: sum of 3 quarters · filed 2019-03-14 | $9.51M 10-K · filed 2019-03-14 |
| 2017-09-30 | $2.74M 10-K · filed 2019-03-14 | $4.94M derived: sum of 2 quarters · filed 2019-03-14 | $6.66M derived: sum of 3 quarters · filed 2019-03-14 | |
| 2017-06-30 | $2.20M 10-K · filed 2019-03-14 | $3.92M derived: sum of 2 quarters · filed 2019-03-14 | ||
| 2017-03-31 | $1.72M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |